O'Connor, C M <br/><br/>
The role of clinical nonfatal end points in cardiovascular phase II/III clinical trials.  [electronic resource] 

 -  American heart journal  Apr 2000 
 - S143-54 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0002-8703 
<br/><br/><label>Standard No.: </label>10.1016/s0002-8703(00)90062-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiovascular Agents--adverse effects<br/>Clinical Trials, Phase II as Topic--statistics & numerical data<br/>Clinical Trials, Phase III as Topic--statistics & numerical data<br/>Humans<br/>Reproducibility of Results<br/>Survival Analysis<br/>Treatment Outcome